HK1014956A1 - Substituted benzoheterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents
Substituted benzoheterocyclic compounds, a process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HK1014956A1 HK1014956A1 HK99100203A HK99100203A HK1014956A1 HK 1014956 A1 HK1014956 A1 HK 1014956A1 HK 99100203 A HK99100203 A HK 99100203A HK 99100203 A HK99100203 A HK 99100203A HK 1014956 A1 HK1014956 A1 HK 1014956A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- alkyl
- cycloalkyl
- aryl
- optionally substituted
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705110A FR2762598A1 (fr) | 1997-04-25 | 1997-04-25 | Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennnent |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1014956A1 true HK1014956A1 (en) | 1999-10-08 |
Family
ID=9506306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK99100203A HK1014956A1 (en) | 1997-04-25 | 1999-01-14 | Substituted benzoheterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
Country Status (19)
Country | Link |
---|---|
US (1) | US5919814A (zh) |
EP (1) | EP0873993B1 (zh) |
JP (1) | JP4125418B2 (zh) |
CN (1) | CN1145622C (zh) |
AT (1) | ATE213496T1 (zh) |
AU (1) | AU736716B2 (zh) |
BR (1) | BR9801448B1 (zh) |
CA (1) | CA2235421C (zh) |
DE (1) | DE69803894T2 (zh) |
DK (1) | DK0873993T3 (zh) |
ES (1) | ES2173556T3 (zh) |
FR (1) | FR2762598A1 (zh) |
HK (1) | HK1014956A1 (zh) |
HU (1) | HU223468B1 (zh) |
NO (1) | NO317742B1 (zh) |
NZ (1) | NZ330279A (zh) |
PL (1) | PL198572B1 (zh) |
PT (1) | PT873993E (zh) |
ZA (1) | ZA983490B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19548708A1 (de) * | 1995-12-23 | 1997-06-26 | Merck Patent Gmbh | Cyclische Sulfone |
FR2799757B1 (fr) * | 1999-10-15 | 2001-12-14 | Adir | Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2805993B1 (fr) * | 2000-03-08 | 2004-01-16 | Adir | Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement du developpement de la tolerance aux composes nitres |
US6750213B2 (en) | 2000-10-19 | 2004-06-15 | Merck & Co., Inc. | Estrogen receptor modulators |
CA2424726A1 (en) * | 2000-10-19 | 2002-04-25 | Merck & Co., Inc. | Estrogen receptor modulators |
WO2003029258A1 (en) * | 2001-10-04 | 2003-04-10 | Akzo Nobel N.V. | Oligomeric, hydroxy-terminated phosphonates |
AU2003237084C1 (en) | 2002-04-24 | 2009-03-26 | Merck Sharp & Dohme Corp. | Estrogen receptor modulators |
FR2918370B1 (fr) * | 2007-07-02 | 2009-08-28 | Servier Lab | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2918372B1 (fr) * | 2007-07-02 | 2009-08-28 | Servier Lab | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
FR2691149B1 (fr) * | 1992-05-18 | 1994-07-08 | Adir | Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2716680B1 (fr) * | 1994-02-25 | 1996-04-05 | Adir | Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-04-25 FR FR9705110A patent/FR2762598A1/fr not_active Withdrawn
-
1998
- 1998-04-20 CA CA002235421A patent/CA2235421C/fr not_active Expired - Fee Related
- 1998-04-22 NO NO19981814A patent/NO317742B1/no unknown
- 1998-04-23 DK DK98400987T patent/DK0873993T3/da active
- 1998-04-23 ES ES98400987T patent/ES2173556T3/es not_active Expired - Lifetime
- 1998-04-23 PT PT98400987T patent/PT873993E/pt unknown
- 1998-04-23 EP EP98400987A patent/EP0873993B1/fr not_active Expired - Lifetime
- 1998-04-23 AT AT98400987T patent/ATE213496T1/de not_active IP Right Cessation
- 1998-04-23 DE DE69803894T patent/DE69803894T2/de not_active Expired - Fee Related
- 1998-04-24 JP JP11497998A patent/JP4125418B2/ja not_active Expired - Fee Related
- 1998-04-24 AU AU63591/98A patent/AU736716B2/en not_active Ceased
- 1998-04-24 ZA ZA983490A patent/ZA983490B/xx unknown
- 1998-04-24 NZ NZ330279A patent/NZ330279A/en unknown
- 1998-04-24 HU HU9800964A patent/HU223468B1/hu not_active IP Right Cessation
- 1998-04-24 US US09/066,235 patent/US5919814A/en not_active Expired - Fee Related
- 1998-04-24 PL PL325989A patent/PL198572B1/pl unknown
- 1998-04-24 BR BRPI9801448-0A patent/BR9801448B1/pt not_active IP Right Cessation
- 1998-04-24 CN CNB981073328A patent/CN1145622C/zh not_active Expired - Fee Related
-
1999
- 1999-01-14 HK HK99100203A patent/HK1014956A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT873993E (pt) | 2002-07-31 |
HUP9800964A3 (en) | 2000-06-28 |
JPH10298178A (ja) | 1998-11-10 |
NO981814L (no) | 1998-10-26 |
AU736716B2 (en) | 2001-08-02 |
FR2762598A1 (fr) | 1998-10-30 |
DE69803894D1 (de) | 2002-03-28 |
CA2235421C (fr) | 2003-09-16 |
HU223468B1 (hu) | 2004-07-28 |
BR9801448B1 (pt) | 2009-01-13 |
CN1197797A (zh) | 1998-11-04 |
NZ330279A (en) | 1998-11-25 |
US5919814A (en) | 1999-07-06 |
EP0873993A1 (fr) | 1998-10-28 |
PL198572B1 (pl) | 2008-06-30 |
HU9800964D0 (en) | 1998-06-29 |
CN1145622C (zh) | 2004-04-14 |
NO981814D0 (no) | 1998-04-22 |
DK0873993T3 (da) | 2002-06-10 |
DE69803894T2 (de) | 2002-11-07 |
EP0873993B1 (fr) | 2002-02-20 |
CA2235421A1 (fr) | 1998-10-25 |
BR9801448A (pt) | 2000-02-08 |
HUP9800964A2 (hu) | 2000-05-28 |
ATE213496T1 (de) | 2002-03-15 |
JP4125418B2 (ja) | 2008-07-30 |
ZA983490B (en) | 1998-10-29 |
NO317742B1 (no) | 2004-12-13 |
AU6359198A (en) | 1998-10-29 |
PL325989A1 (en) | 1998-10-26 |
ES2173556T3 (es) | 2002-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69005248D1 (de) | 2-Aminopyrimidin-3-oxid-Derivate enthaltende Zusammensetzungen zur Verwendung zum Vermindern des Haarausfalles und zum Induzieren und Stimulieren des Haarwuchses und neue von 2-Aminopyrimidin-3-oxid abgeleitete Verbindungen. | |
DE69207194D1 (de) | Verfahren zur Herstellung von Bacchatin III und von Desacetyl-10-Bacchatin III Derivate | |
ZA964484B (en) | Alkoxyaryl compounds their process of preparation and the pharmaceutical compositions which contain them | |
HK1014956A1 (en) | Substituted benzoheterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them | |
GR3037038T3 (en) | Chromene derivatives, process for their preparation and pharmaceutical compositions containing them | |
NZ240575A (en) | N-benzoylproline derivatives and pharmaceutical compositions | |
IL117150A (en) | Substituted benzenesulfonylureas and - thioureas processes for their preparation their use in the preparation of medicaments and pharmaceutical compositions containing them | |
AU4872793A (en) | New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them | |
DE69603309D1 (de) | Tricyclische Amidverbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
DK406587D0 (da) | 1,4-dihydropyridinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
ZA88208B (en) | Sweetening agents derived from guanidinoacetic and ethanamidinoacetic acids,process for sweetening various products,and compositions containing such sweetening agents | |
DE68922596D1 (de) | 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen. | |
ATE89551T1 (de) | Verfahren zur herstellung von optisch aktiven acyloxyazetidinonen. | |
AU4930797A (en) | New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20090424 |